Low frequency of autoantibodies against Ki-67 antigen in Japanese patients with systemic autoimmune diseases

Journal of Autoimmunity

Volumn 10, Issue 5, 1997, Pages 499-503

  Muro, Yoshinao ^a   Kano, Takahisa ^a   Sugiura, Kazumitsu ^a   Hagiwara, Masatoshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibodies; Autoantigens; cDNA cloning; Ki 67; Nucleolus

Indexed keywords

AUTOANTIBODY; KI 67 ANTIGEN;

AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; DNA LIBRARY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; JAPAN; MAJOR CLINICAL STUDY; MOLECULAR CLONING; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030880004     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0157     Document Type: Article

References (22)

1. von Muhlen C.A., Tan E.M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum. 24:1995;323-358.
2. Bloch D.B., Rabkina D., Bloch K.D. The cell proliferation-associated protein Ki-67 is a target of autoantibodies in the serum of MRL mice. Lab. Invest. 73:1995;366-371.
3. Gerdes J., Lemke H., Baisch H., Wacker H.-H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133:1984;1710-1715.
4. Verheijen R., Kuijpers H.J.H., Schlingemann R.O., Boemher A.L.M., van Driel R., Brakenhoff G.J., Ramaekers F.C.S. Ki-67 detects a nuclear matrix-associated proliferation-related antigen I intra-cellular localization during interphase. J. Cell Sci. 92:1989;123-130.
5. Verheijen R., Kuijpers H.J.H., van Driel R., Beck J.L.M., van Dierendonck J.H., Brakenhoff G.J., Ramaekers F.C.S. Ki-67 detects a nuclear matrix-associated proliferation-related antigen II localization in mitotic cells and association with chromosomes. J. Cell Sci. 92:1989;531-540.
6. Schluter C., Duchrow M., Wohlenberg C., Becker M.H.G., Key G., Flad H.-D., Gerdes J. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol. 123:1993;513-522.
7. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1277.
8. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., Medsger T.A. Jr., Mitchell D.M., Neustadt D.H., Pinals R.S., Schaller J.G., Sharp J.T., Wilder R.L., Hunder G.G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
9. Bohan A., Peter J.B. Polymyositis and dermatomyositis. N. Eng. J. Med. 292:1975;344-347.
10. Homma M., Tojo T., Akizuki M., Yamagata H. Criteria for Sjogren's syndrome in Japan. Scand. J. Rheumatol. (Suppl). 61:1986;26-27.
11. Kasukawa R., Tojo T., Miyawaki S., Yoshida H., Tanimoto K., Nobunaga M., Suzuki T., Takasaki Y., Tamura T. Preliminary diagnostic criteria for classification of mixed connective tissue disease. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies. 1987;Excerpta Medica, Amsterdam.
12. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23:1980;581-590.
13. Moriguchi T., Kuroyanagi N., Yamaguchi K. A novel kinase mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 271:1996;13675-13679.
14. Muro Y., Chan E.K., Landberg G., Tan E.M. A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells. Biochem. Biophys. Res. Commun. 207:1995;1029-1037.
15. Muro Y., Sugimoto K., Okazaki T., Ohashi M. The heterogeneity of anticentromere antibodies in immunoblotting analysis. J. Rheumatol. 17:1990;1042-1047.
16. Muro Y., Tsai W.-M., Houghten R., Tan E.M. Synthetic compound peptide simulating antigenicity of conformation-dependent autoepitope. J. Biol. Chem. 269:1994;18529-18534.
17. Gerdes J., Schwab U., Lemke H., Stein H. Production of a monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer. 31:1983;13-20.
18. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin. Cancer Biol. 1:1990;99-206.
19. Rogers S., Wells R., Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science. 234:1986;364-368.
20. Starborg M., Gell K., Brundell E., Hoog C. The murine Ki-67 cell proliferation antigen accumulates in the nucleolar and heterochromatic regions of interphase cells and at the periphery of the mitotic chromosomes in a process essential for cell cycle progression. J. Cell Sci. 109:1996;143-153.
21. Tan E.M., Muro Y., Pollard K.M. Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions. Clin. Exp. Rheumatol. 12(Suppl 11):1994;S27-S31.
22. Gerdes J., Li L., Schlueter C., Duchrow M., Wohlenberg C., Gerlach C., Stahmer I., Kloth S., Brandt E., Flad H.-D. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 138:1991;867-873.